neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.050

-3.9%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kramer who wrote ()	10/8/1998 12:29:00 AM
From: Kramer	Read Replies (1) of 441

I'm expecting the consensus EPS estimates to be raised to at least the current high analyst estimate of 52 cents for the year. In the conference call they indicated that 2 cents was eaten up this quarter in legal fees and that one way or another this expense would be over when the case goes to court in late October or early November. A win would mean a judgement of at least 4 cents a share; worst case would be that for half of this quarter we wouldn't be chewing up another penny in legal expenses, and 2 cents in quarters 3 and 4 (another 4 cents). So this alone could mean another 5 cents added to next quarter and 4 cents for rest of the year after that. Based on the CC comments that they expect to maintain these revenue levels, If sales remained flat for the rest of the year (quarter to quarter) we would be at 52 cents and then add the 9 cents to that. Gee!, right now we're at a PE of 11 based on this years EPS (at a minimum). And with a growth rate of 20 to 30%, neog should deserve a price of $12 at a minimum.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next